3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Urinary Bladder Neoplasms
13
Glioblastoma
4
Brain Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Glioma
2
Astrocytoma
2
Urothelial Carcinoma of the Bladder
1
Prostatic Hyperplasia
1
Pathologic Complete Response
1
Paranasal Sinus Neoplasms
1
Oligodendroglioma
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Muscle-invasive Urothelial Cancer of the Bladder
1
Mouth Neoplasms
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Laryngeal Neoplasms
1
Ganglioneuroblastoma
1
Estrogen Receptor Positive Breast Cancer
1
Ependymoma
1
Craniopharyngioma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Interventions
Fulvestrant
2
vistusertib
1
proto-oncogene protein c-fes-fps
1
capivasertib
1
Transurethral Resection of Bladder
1
Hydroxychloroquine
1
Everolimus
1
Estrogens
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Estrogen Receptor Positive Breast Cancer
×
Transurethral Resection of Bladder
×
Clear all
NCT06629233
2025-08-29
Tn-Miner
University Ghent
Phase NA
Enrolling by invitation
36 enrolled